Brief: Delcath Systems Announces Investigator-Initiated Chopin Phase 2 Trial Presentation At ESMO 2025 Congress
22/09/2025 21:54
Sept 22 (Reuters) - Delcath Systems Inc DCTH.O: DELCATH SYSTEMS ANNOUNCES INVESTIGATOR-INITIATED CHOPIN PHASE 2 TRIAL PRESENTATION AT ESMO 2025 CONGRESS Source text: ID:nBw1qXhCsa Further company coverage: DCTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Highlights Clinical Program Presentations At Esmo Congress 2026 And Independent Data On Percutaneous Hepatic Perfusion In Liver-Dominant Metastatic Uveal Melanoma
Brief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Delcath Systems Q2 revenue rises, beats estimates
Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview